Future Direction of the DRCR Retina Network

Related

• 

  Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)

  Quan Dong Nguyen, MD, MSc, FARVO, FASRS

  Annual Meeting Talks

  2021

• 

  Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)

  Victor Hugo Gonzalez, MD

  Annual Meeting Talks

  2024

• 

  Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial

  Nancy M. Holekamp, MD, FASRS

  Updates from the Field

  2016